Raymond James analyst Laura Prendergast initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform rating and announces Price Target of $20.
Raymond James Initiates Coverage On Black Diamond Therapeutic With Outperform Rating, Announces Price Target of $20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.